Catalyst Wire Dossier Catalyst Wire Dossier

abatacept (generic)

abatacept
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for abatacept (generic), covering 2022-09-23 to 2022-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis [Phase 3]

See pricing